Travere Therapeutics - M&A Summary and Business Overview

Life ScienceCompany

Travere Therapeutics M&A Summary

Travere Therapeutics has acquired 3 companies.

Travere Therapeutics’ largest acquisition to date was in 2014, when it acquired Manchester Pharmaceuticals for $63M. Travere Therapeutics has acquired in 3 different US states. The Company’s most targeted sectors include life science (100%).

Travere Therapeutics Business Overview

Where is Travere Therapeutics headquartered?

Travere Therapeutics is headquartered in San Diego, California.

What is Travere Therapeutics’ revenue?

Travere Therapeutics disclosed revenue of 198M USD for 2020 and 175M USD for 2019.

How many employees does Travere Therapeutics have?

Travere Therapeutics has 221 employees.

What sector is Travere Therapeutics in?

Travere Therapeutics is a life science company.

When was Travere Therapeutics founded?

Travere Therapeutics was founded in 2011.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Travere Therapeutics

Travere Therapeutics, Inc.

3611 Valley Centre Drive Suite 300,
San Diego, California 92130
United States,
(888) 969-7879
www.travere.com

Travere Therapeutics is a fully integrated biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options. The Company's approach centers on its pipeline featuring clinical-stage assets targeting rare diseases with significant unmet medical needs, including sparsentan for focal segmental glomerulosclerosis (FSGS), a disorder characterized by progressive scarring of the kidney often leading to end-stage renal disease, and RE-024 for pantothenate kinase-associated neurodegeneration (PKAN), a life-threatening neurological disorder that typically begins in early childhood. Research exploring the potential of early-stage assets in several rare diseases is also underway. Travere Therapeutics was founded in 2011 and is based in San Diego, California.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $63M $63M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Asklepion - Liquid Formulation Of Ursodeoxycholic Acid 2016-06-20 - Divestiture
, United States
Manchester Pharmaceuticals, Inc. 2014-02-12 63M USD Add-on Acquisition
Fort Collins, Colorado · www.manchesterpharma.com
Kyalin Biosciences, Inc. 2013-12-12 - Add-on Acquisition
Encinitas, California · www.kyalinbio.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 63M (100%) - -
Total 3 $63M - -

By Geo

State/Country Buy Value Sell Value
United States 3 63M - -
  Colorado 1 63M - -
  California 1 - - -
Total 3 $63M - -

Deal Values

buy # Total
< $100M 1 $63M
TOTAL $63M
Largest Manchester Pharmaceuticals, Inc.
$63M (2014-02-12)

M&A Connections

Deals
Acquired from
Strategic(s)
33%
1 (33%)

Company Summary

SECTOR

Life Science

Revenue

198   14% 2020
175   7% 2019
164   6% 2018
155   16% 2017
134   34% 2016
100   258% 2015
28   2014
(millions of USD) Show More Show Less

Employees

221

Established

2011

Public

NASDAQ: TVTX

Former Name

Retrophin, Inc.

 Subscribe to unlock this and 202,135
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 193K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Travere Therapeutics

California Companies , Life Science Companies , United States Companies , California Life Science Companies , California Life Science with Acquisitions , California Life Science with Divestitures

Related Lists for California Companies

Largest California Companies , Acquisitive California Companies , Recently Acquired California Companies , Recently Sold California Companies , Private California Companies , Public California Companies , Acquired California Companies , PE Backed California Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal